Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Share News (FEVR)

Share Price Information for Fevertree (FEVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,005.00
Bid: 1,010.00
Ask: 1,013.00
Change: -1.00 (-0.10%)
Spread: 3.00 (0.297%)
Open: 1,036.00
High: 1,036.00
Low: 1,002.00
Prev. Close: 1,006.00
FEVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Deutsche Bank starts coverage of Fevetree, Britvic at 'buy'

Tue, 30th Apr 2024 14:21

(Sharecast News) - Deutsche Bank initiated coverage of drinks companies Fevertree and Britvic on Tuesday with 'buy' rating.

The bank put a 1,600p price target on Fevertree, as it said the investment thesis is underpinned by a leading position in the premiumisation of the global mixer category.

"We believe in the long-term premiumisation opportunity and think Fevertree is well positioned given its first-mover advantage, strong brand credentials, high-quality products and capital-light business model," DB said.

"After two years of challenging performance, we are confident in a strong margin recovery this year and over the medium term and do not believe the recent margin dilution is structural.

"We also believe in the longer-term revenue potential of global mixer premiumisation. We do not think these are being fully captured in the current share price."

Deutsche set a 1,040p price target on Britvic. It noted that the company's most important segment is its GB business, which accounts for around 75% of group profitability.

"Underpinned by the Pepsi bottling contract and market leading position in squash via the Robinsons brand, we think there is further room for growth via market share gains and additional distribution," it said.

"This should be delivered against a well-invested asset base which has not yet realised its full margin potential. We think the streamlined overseas strategy is sensible, providing a more focused and simplified approach with higher margin potential."

DB said it thinks its forecasts of a 4.5% revenue compound annual growth rate and an 8.1% adjusted operating profit CAGR across FY23-27 look well underpinned, "reflecting an easing inflationary backdrop, operational leverage from additional volumes and efficiencies derived from a well-invested asset base".

In addition, healthy free cash generation should support further shareholder returns, which have contributed to a strong total shareholder return performance versus its peers over recent years.

More News
27 Jan 2022 09:37

Fevertree shares run out of fizz on margins warning

(Sharecast News) - Shares in Fevertree Drinks plunged on Thursday after the company said margins would be hit harder than expected due to higher costs and logistics issues.

Read more
18 Jan 2022 11:24

Jefferies upgrades Fever Tree to 'buy' on US opportunity

(Sharecast News) - Analysts at Jefferies hiked their target price for shares of Fever-Tree and upgraded their recommendation for the shares to 'buy', telling clients that it was a "leveraged play on spirits premiumisation trends and was uniquely positioned to lead and grow the premium mixers market".

Read more
18 Jan 2022 09:44

LONDON BROKER RATINGS: Goldman Sachs raises BT to Conviction Buy

LONDON BROKER RATINGS: Goldman Sachs raises BT to Conviction Buy

Read more
18 Jan 2022 08:24

LONDON BRIEFING: THG warns on margins, promises more from Ingenuity

LONDON BRIEFING: THG warns on margins, promises more from Ingenuity

Read more
13 Jan 2022 09:10

TOP NEWS: Retailer ASOS now to be seen on London Main Market

TOP NEWS: Retailer ASOS now to be seen on London Main Market

Read more
20 Dec 2021 09:38

LONDON BROKER RATINGS: Shore raises Keywords; HSBC cuts boohoo

LONDON BROKER RATINGS: Shore raises Keywords; HSBC cuts boohoo

Read more
20 Dec 2021 08:14

LONDON BRIEFING: Rolls-Royce gets Qatar money for mini-nuclear plants

LONDON BRIEFING: Rolls-Royce gets Qatar money for mini-nuclear plants

Read more
14 Dec 2021 09:40

LONDON BROKER RATINGS: JPMorgan raises Experian, cuts BAE Systems

LONDON BROKER RATINGS: JPMorgan raises Experian, cuts BAE Systems

Read more
30 Nov 2021 09:43

LONDON BROKER RATINGS: JPMorgan upgrades Coca-Cola HBC to Overweight

LONDON BROKER RATINGS: JPMorgan upgrades Coca-Cola HBC to Overweight

Read more
1 Nov 2021 09:38

LONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest

LONDON BROKER RATINGS: Upgrades for Lloyds Banking and NatWest

Read more
1 Nov 2021 08:11

LONDON BRIEFING: Barclays names head of Global Markets as new CEO

LONDON BRIEFING: Barclays names head of Global Markets as new CEO

Read more
15 Oct 2021 15:59

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
14 Oct 2021 09:42

LONDON BROKER RATINGS: Jefferies cuts Johnson Matthey to Underperform

LONDON BROKER RATINGS: Jefferies cuts Johnson Matthey to Underperform

Read more
12 Oct 2021 11:00

HSBC downgrades Fevertree despite 'strong' sales in Germany, Italy and US

(Sharecast News) - HSBC analysts downgraded their recommendation for shares of Fevertree from 'buy' to 'hold', telling clients that they now saw "limited upside" in the share price.

Read more
7 Oct 2021 09:40

LONDON BROKER RATINGS: Morgan Stanley upgrades Centrica to Overweight

LONDON BROKER RATINGS: Morgan Stanley upgrades Centrica to Overweight

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.